MedTrace Logo

Patient Characteristics in Daily Radiological Practice of Gadovist® Application (PATRON)

NCT00874640 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3711

Last updated 2014-02-20

No results posted yet for this study

Summary

To evaluate patient characteristics in the current daily radiological practice of Gadovist application. Special focus will be laid on the individual risk factors of patients, the indications for and the dose of Gadovist application.

Secondary objective is to prove the known safety profile (especially rare adverse events) of Gadovist and to collect data on handling problems with different application forms (one questionnaire per center).

Conditions

  • Epidemiologic Factors

Interventions

BIOLOGICAL

Gadobutrol (Gadovist, BAY86-4875)

Patients with indication for a MRT or MR-Angiography and for whom the radiologist has decided to use the contrast medium gadobutrol

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-09-30
Completion
2011-11-30

Countries

  • Germany

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00874640 on ClinicalTrials.gov